Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2247
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Holdsworth-Carson, Sarah | - |
dc.contributor.other | Rao, Sushma | - |
dc.contributor.other | Boughton, Berin | - |
dc.contributor.other | Snel, Marten | - |
dc.contributor.other | Pukala, Tara | - |
dc.contributor.other | Griffiths, Meaghan | - |
dc.contributor.other | Rogers, Peter | - |
dc.contributor.other | Girling, Jane | - |
dc.date.accessioned | 2023-10-06T00:18:31Z | - |
dc.date.available | 2023-10-06T00:18:31Z | - |
dc.date.issued | 2023-10 | - |
dc.identifier.uri | http://hdl.handle.net/11434/2247 | - |
dc.description.abstract | Background and Aim: Endometriosis diagnosis requires surgical visualisation of lesions and histopathology. To date, no non-invasive diagnostic test has been validated. Discovery research using sensitive high-throughput mass spectrometry (MS) has the potential to improve identification of clinically-relevant plasma proteins.The aim of this study was to undertake MS-based proteomic biomarker discovery using minimally-invasive plasma specimens from patients with and without endometriosis.Conclusions: High-throughput MS-based proteomic biomarker discovery successfully identified 470 proteins in an endometriosis cohort. Case-control analysis revealed significantly different protein expression profiles in association with endometriosis. Further validation in an independent sample set is underway. Biomarker discovery using plasma proteomics offers a minimally invasive approach to endometriosis diagnosis. | en_US |
dc.subject | Endometriosis | en_US |
dc.subject | Mass Spectrometry | en_US |
dc.subject | MS | en_US |
dc.subject | Proteomic Biomarker | en_US |
dc.subject | Plasma | en_US |
dc.subject | Plasma Proteins | en_US |
dc.subject | . Julia Argyrou Endometriosis Centre, Epworth HealthCare, Victoria, Australia | en_US |
dc.title | Plasma mass spectrometry-based proteomic biomarker discovery for endometriosis. | en_US |
dc.type | Conference Poster | en_US |
dc.description.affiliates | South Australian Health and Medical Research Institute, Adelaide, SA, Australia | en_US |
dc.description.affiliates | Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia | en_US |
dc.description.affiliates | Australian National Phenome Centre, Harry Perkins Institute of Medical Research, Murdoch, WA, Australia | en_US |
dc.description.affiliates | School of Physical Sciences, University of Adelaide, Adelaide, SA, Australia | en_US |
dc.description.affiliates | Department of Obstetrics and Gynaecology, University of Melbourne and Gynaecology Research Centre, Royal Women’s Hospital, Parkville, VIC, Australia | en_US |
dc.description.affiliates | Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand | en_US |
dc.type.studyortrial | Case Control Studies | en_US |
dc.description.conferencename | Epworth HealthCare Research Month 2023 | en_US |
dc.description.conferencelocation | Epworth Research Institute, Victoria, Australia | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Research Week |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
JAECE Research Poster Human Plasma Study (Nov22)_SCarson.pdf | 482.96 kB | Adobe PDF | View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.